ACLS Provider: Course

Incorrect. Chest compressions are performed to dislodge the obstruction and restore effective ventilation in an unresponsive infant.

Incorrect. Two minutes of CPR (about 5 cycles of 30 compressions and 2 breaths) should be completed before checking the rhythm.

Incorrect. Pediatric defibrillation begins at 2 J/kg and increases to 4 J/kg for subsequent shocks if needed.

Incorrect. Magnesium sulfate stabilizes cardiac myocytes and is the drug of choice for treating torsades de pointes.

Incorrect. The compression fraction should be greater than 80% to maximize perfusion during CPR.

Incorrect. Waveform capnography provides real-time confirmation of ET tube placement and ensures proper ventilation.

Incorrect. IM epinephrine is the first-line treatment for anaphylaxis, administered into the mid-thigh for rapid absorption.

Incorrect. Biphasic defibrillation begins at 120-200 J to terminate shockable rhythms like VF and pulseless VT effectively.

Incorrect. TTM helps reduce neurological injury after ROSC by maintaining a target temperature between 32-36°C.

Incorrect. Targeted temperature management improves neurological outcomes by preventing further brain injury.

Incorrect. VF is a shockable rhythm, and immediate defibrillation is the most effective treatment.

Incorrect. Two minutes of CPR (about 5 cycles of 30 compressions and 2 breaths) should be performed before reassessing the rhythm.

Incorrect. Calcium gluconate stabilizes the cardiac membrane and reduces the risk of life-threatening arrhythmias caused by hyperkalemia.

Incorrect. Asystole is a non-shockable rhythm and is treated with high-quality CPR and epinephrine administration.

Incorrect. Delivering 6-8 breaths per minute ensures adequate oxygenation without hyperventilation during CPR with an advanced airway.

Incorrect. Amiodarone is preferred, but lidocaine is an alternative antiarrhythmic for refractory VF or pulseless VT.

Incorrect. Atropine blocks vagal stimulation, increasing heart rate in cases of symptomatic bradycardia.

Incorrect. Maintaining oxygen saturation within this range ensures adequate oxygenation without the risk of hyperoxia.

Incorrect. Pulseless VT is a shockable rhythm requiring immediate defibrillation to restore organized cardiac activity.

Incorrect. PEA is not treated with adenosine; it is managed with CPR, epinephrine, and identifying and treating reversible causes.

Incorrect. Hypoxia is the most frequent reversible cause of PEA and should be addressed immediately with oxygenation and ventilation.

Incorrect. Avoid delays to minimize interruptions in chest compressions and maintain perfusion.

Incorrect. Pediatric defibrillation starts at 2 J/kg for the initial shock, increasing as needed based on the patient's response.

Incorrect. A compression fraction >80% is required to maximize perfusion and improve survival rates during high-quality CPR.

Incorrect. Rotating team roles every 2 minutes prevents fatigue, ensuring consistent delivery of high-quality chest compressions.

Incorrect. VF is a shockable rhythm requiring immediate defibrillation to restore organized electrical activity.

Incorrect. Providing 6-8 breaths per minute ensures adequate oxygenation and ventilation without interfering with chest compressions.

Incorrect. CPR is the primary treatment for PEA, along with epinephrine and addressing reversible causes to restore circulation.

Incorrect. Post-ROSC care focuses on maintaining oxygenation and avoiding hypoxia or hyperoxia to protect organ function.

Incorrect. With an advanced airway, compressions continue uninterrupted while ventilation is provided at a rate of 10 breaths per minute.

Incorrect. Early defibrillation within 30 seconds of a witnessed VF arrest increases survival rates significantly.

Incorrect. A PETCO2 level greater than 10 mmHg indicates that chest compressions are generating adequate blood flow.

Incorrect. Lidocaine is an alternative antiarrhythmic for refractory VF, dosed at 1 mg/kg IV/IO.

Incorrect. A rate of 100-120 compressions per minute ensures adequate circulation without risking incomplete recoil or excessive fatigue.

Incorrect. Maintaining oxygen saturation at 92-96% prevents hypoxia and avoids complications associated with hyperoxia.

Incorrect. Pulseless VT is treated with defibrillation, not atropine. Atropine is used for symptomatic bradycardia.

Incorrect. Epinephrine at 0.01 mg/kg IV/IO is administered every 3-5 minutes to enhance coronary and cerebral perfusion in children.

Incorrect. Amiodarone 300 mg IV/IO is administered after defibrillation and epinephrine to treat refractory VF or pulseless VT.

Incorrect. Pediatric defibrillation begins at 2 J/kg for the first shock and increases as necessary for subsequent shocks.

Incorrect. Biphasic defibrillators deliver effective shocks within the range of 120-200 J, restoring organized electrical activity.

Incorrect. Epinephrine is given at a dose of 1 mg IV/IO every 3-5 minutes during adult cardiac arrest to improve perfusion.

Incorrect. Atrial fibrillation is cardioverted starting at 120-200 J in synchronized mode to avoid delivering the shock during ventricular repolarization.

Incorrect. PETCO2 readings above 10 mmHg during CPR indicate adequate chest compressions and cardiac output.

Incorrect. Switching every 2 minutes reduces rescuer fatigue and ensures high-quality chest compressions.

Incorrect. Atropine is the first-line drug for treating symptomatic bradycardia by increasing heart rate through vagal inhibition.

Incorrect. Adenosine is administered as a 6 mg rapid IV push, followed by a saline flush, to terminate reentrant arrhythmias.

Incorrect. The correct compression rate for CPR is 100-120 compressions per minute to optimize perfusion and prevent fatigue.

Incorrect. TTM helps reduce neurological injury by maintaining a core temperature of 32-36°C after the return of spontaneous circulation.

Incorrect. If VF persists after defibrillation and epinephrine, amiodarone is administered to stabilize the rhythm.

Incorrect. Ventilations are delivered at a rate of 6-8 breaths per minute to prevent hyperventilation.

Incorrect. Epinephrine is administered to increase coronary and cerebral perfusion pressure during cardiac arrest.

Incorrect. VF is a shockable rhythm, and defibrillation is the most effective intervention to restore a normal rhythm.

Incorrect. Rhythm checks are performed every 2 minutes to evaluate for shockable rhythms and assess the effectiveness of interventions.

Incorrect. Magnesium sulfate stabilizes the myocardium and is the first-line treatment for torsades de pointes.

Incorrect. High-quality CPR should be resumed immediately after defibrillation to maintain perfusion and increase chances of ROSC.

Incorrect. Atropine should not exceed a total dose of 3 mg when treating symptomatic bradycardia in adults.

Incorrect. A rate of 100-120 compressions per minute optimizes perfusion without compromising cardiac filling.

Incorrect. Amiodarone is administered as a 300 mg IV/IO bolus for refractory VF or pulseless VT.

Incorrect. Magnesium sulfate is administered to stabilize the myocardium and treat torsades de pointes effectively.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and must be corrected to restore spontaneous circulation.

Incorrect. A compression fraction greater than 80% ensures that most of the resuscitation time is spent performing chest compressions.

Incorrect. Adenosine is administered at 0.1 mg/kg as a rapid IV push for terminating narrow-complex SVT caused by reentrant pathways.

Incorrect. PEA is not a shockable rhythm; it is treated with CPR and addressing reversible causes such as hypoxia or hypovolemia.

Incorrect. Post-ROSC care focuses on stabilizing ventilation and oxygenation to prevent hypoxia or hyperoxia.

Incorrect. While hypoglycemia can cause critical symptoms, it is not included in the H's and T's of reversible causes of cardiac arrest.